Using an accelerated course of radiation therapy “does not increase complications” in patients who undergo breast reconstruction after a mastectomy, according to results from the phase III RT CHARM trial presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting. The study is the “first multi-institutional international study to show that a shorter course of post-mastectomy radiation, combined with breast reconstruction, is safe and effective,” according to ASTRO officials. Matthew M. Poppe, MD, FASTRO, the principal investigator of the trial and a professor of radiation oncology at the University of ...
Advertisement
Latest News
The panel used an iterative process to create patient-facing and provider-facing consensus statements across 7 domains.
Amy Pierre, RN, BSN, ANP-BC, shares her insights on disparities in myeloma and the steps APPs can take to address them.
New research highlights the need for “early and equitable” integration of palliative care for patients with myeloma.
It's critical for oncology nurses to encourage these patients to monitor their blood pressure at home.
Renal toxicity occurs in approximately 75% of all patients who receive allogeneic stem cell transplants.
The first-of-its kind clinical trial was presented at the 2024 ASTRO Annual Meeting.
Blood Cancer Awareness Month represents a critical opportunity to provide education on early signs and symptoms.
A team used an interpretive description approach to evaluate the self-management support intervention.
Women with deep infiltrating endometriosis and/or ovarian endometriosis had the highest risk for ovarian cancer.
Learn how a team implemented pre-screening and fast-track strategies to increase clinical trial enrollment in these patients.
New research highlights the importance of using appropriate patient-reported outcome measures for these patients.
The study investigators say the 5-year survival rate "dramatically exceeds historical standards."
Advertisement
Advertisement
Our Contributors
Theresa Brown, RNTheresa Brown, RN, is the New York Times best-selling author of "Healing" and "The Shift."
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC.
Milagros Elia, MA, APRN, ANP-BCMilagros R. Elia, MA, APRN, ANP-BC, has 25+ years of oncology experience and is a highly regarded activist.
Pamela K. Ginex, EdD, MPH, RN, OCNPamela K. Ginex, EdD, MPH, RN, OCN, is an Assistant Professor at the Stony Brook University School of Nursing.
Teresa Hagan Thomas, PhD, RNTeresa Hagan Thomas, PhD, RN, is an Assistant Professor at the University of Pittsburgh School of Nursing.
Amanda Brink, DNP, APRN, FNP-BC, AOCNPAmanda Brink, DNP, APRN, FNP-BC, AOCNP, is an oncology nurse practitioner at the MD Anderson Cancer Center.
Alicia Michaelsen, BSN, RN, BMTCN®Alicia Michaelsen, BSN, RN, BMTCN®, is a nurse with over a decade of experience.
Fatemeh Youssefi, PhD, RN, OCNFatemeh Youssefi, PhD, RN, OCN, is a nurse who has specialized in oncology for the past 20 years.
Expert Interviews
Cancer Nursing Today delivers critical news and expert insights to support oncology nurses throughout their education and careers.
Sign up to receive Cancer Nursing Today eNewsletters:
Conference Highlights
The panel used an iterative process to create patient-facing and provider-facing consensus statements across 7 domains.
New research highlights the need for “early and equitable” integration of palliative care for patients with myeloma.
The study investigators say the 5-year survival rate "dramatically exceeds historical standards."
Learn what a team found when they implemented a pre-appointment electronic PRO measure for patients with prostate cancer.
